COMBINATION CYTOKINE THERAPY PREVENTS HUMAN EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE (EBV-LPD) IN THE HUMAN-PBL-SCID MOUSE MODEL - CRITICAL ROLE OF HUMAN NATURAL-KILLER (NK) CELLS

Citation
Ra. Baiocchi et al., COMBINATION CYTOKINE THERAPY PREVENTS HUMAN EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE (EBV-LPD) IN THE HUMAN-PBL-SCID MOUSE MODEL - CRITICAL ROLE OF HUMAN NATURAL-KILLER (NK) CELLS, Blood, 90(10), 1997, pp. 2279-2279
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
90
Issue
10
Year of publication
1997
Part
1
Supplement
1
Pages
2279 - 2279
Database
ISI
SICI code
0006-4971(1997)90:10<2279:CCTPHE>2.0.ZU;2-0